To test whether the blockade of the TWIST1-upregulated PD-L1 in breast cancer cells to bind to PD-1 in the CD8+ T cells can enhance the function of CD8+ T cells to kill the breast cancer cells, we treated the cocultures with a PD-L1-neutralizing antibody. This evidence concerns the gene CD274 and breast carcinoma.